| Metric | Q4 2025 | Q3 2025 | Q4 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $5.4B | — | — | — | — |
| Op. Income | $1.6B | — | — | — | — |
| Gross Margin | 31.1% | — | — | — | — |
| Net Margin | 42.4% | — | — | — | — |
| EPS (Diluted) | $10.68 | — | — | — | — |
| Free Cash Flow | $1.3B | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $5.4B |
| Cost of Revenue | $3.7B |
| GROSS PROFIT | $1.7B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $87M |
| Other Expenses | $0 |
| Operating Expenses | $87M |
| Cost & Expenses | $3.8B |
| OPERATING INCOME | $1.6B |
| Interest Income | $15M |
| Interest Expense | $246M |
| Other Income/Expenses | $2.0B |
| INCOME BEFORE TAX | $3.6B |
| Income Tax Expense | $638M |
| Net Income from Continuing Ops | $2.9B |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $2.3B |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $2.3B |
| D&A | $508M |
| EBIT | $3.8B |
| EBITDA | $4.3B |
| EPS | $11 |
| EPS Diluted | $11 |
| Item | Amount |
|---|---|
| REVENUE | $5.4B |
| Cost of Revenue | $3.7B |
| GROSS PROFIT | $1.7B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $87M |
| Other Expenses | $0 |
| Operating Expenses | $87M |
| Cost & Expenses | $3.8B |
| OPERATING INCOME | $1.6B |
| Interest Income | $15M |
| Interest Expense | $246M |
| Other Income/Expenses | $2.0B |
| INCOME BEFORE TAX | $3.6B |
| Income Tax Expense | $638M |
| Net Income from Continuing Ops | $2.9B |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $2.3B |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $2.3B |
| D&A | $508M |
| EBIT | $3.8B |
| EBITDA | $4.3B |
| EPS | $11 |
| EPS Diluted | $11 |
| Item | Amount |
|---|---|
| Net Income | $2.3B |
| Depreciation & Amortization | $508M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $632M |
| Other Non-Cash Items | -$1.5B |
| Change in Working Capital | $150M |
| OPERATING CASH FLOW | $2.1B |
| Capital Expenditure | -$744M |
| Acquisitions (Net) | $14M |
| Purchases of Investments | -$2M |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$3M |
| NET CASH FROM INVESTING | -$735M |
| Net Debt Issuance | $250M |
| Common Stock Repurchased | -$1.0B |
| Common Dividends Paid | -$119M |
| Other Financing Activities | -$228M |
| NET CASH FROM FINANCING | -$1.1B |
| FREE CASH FLOW | $1.3B |
| Net Change in Cash | $186M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $1.6B |
| Short-Term Investments | $0 |
| Net Receivables | $1.4B |
| Inventory | $524M |
| Other Current Assets | $204M |
| TOTAL CURRENT ASSETS | $3.7B |
| PP&E (Net) | $38.5B |
| Goodwill | $77M |
| Intangible Assets | $0 |
| Long-Term Investments | $5.1B |
| Tax Assets | $1.3B |
| Other Non-Current Assets | $511M |
| TOTAL NON-CURRENT ASSETS | $45.4B |
| TOTAL ASSETS | $49.1B |
| Account Payables | $123M |
| Short-Term Debt | $933M |
| Deferred Revenue | $150M |
| Other Current Liabilities | $2.5B |
| TOTAL CURRENT LIABILITIES | $3.9B |
| Long-Term Debt | $24.7B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $4.9B |
| Other Non-Current Liabilities | -$486M |
| TOTAL NON-CURRENT LIABILITIES | $32.1B |
| TOTAL LIABILITIES | $36.0B |
| Common Stock | $1M |
| Additional Paid-In Capital | $4.5B |
| Retained Earnings | $12.2B |
| Treasury Stock | -$8.9B |
| Accum. Other Comp. Income | $0 |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $7.9B |
| Minority Interest | $5.2B |
| TOTAL EQUITY | $13.1B |
| TOTAL LIABILITIES & EQUITY | $49.1B |
| Total Debt | $28.6B |
| Net Debt | $27.0B |
